The Medical Letter on Drugs and Therapeutics: Difference between revisions

*The Medical Letter on Drugs and Therapeutics*
Discipline	Pharmacology
Language	English, French, Italian
Publication details
History	1959-present
Publisher	The Medical Letter, Inc.
Frequency	Biweekly
Standard abbreviations;
ISO 4	Med. Lett. Drugs Ther.
Indexing;
CODEN	MELEAP
ISSN	1523-2859;
LCCN	00211546
OCLC no.	40606056
Links
	Journal homepage;

Browse history interactively

← Previous edit

Content deleted Content added

VisualWikitext

Inline

Latest revision as of 17:53, 6 January 2024

The Medical Letter on Drugs and Therapeutics (commonly referred to as The Medical Letter) is a peer-reviewed biweekly medical journal providing evaluations of pharmaceutical drugs. It is published in English, French, and Italian. The journal is abstracted and indexed in Index medicus/MEDLINE/PubMed. An offshoot, Treatment Guidelines from the Medical Letter (ISSN 1541-2792) was published from 2002 to 2014, when it was integrated into this journal.

Editorial process

Articles for The Medical Letter are drafted by either an editor or external consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of clinical trials. A preliminary draft is circulated to every member of the advisory board and 10-20 other investigators with relevant clinical or experimental experience with the article's topic. Drafts are also provided to the Food and Drug Administration and Centers for Disease Control and Prevention and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents. The final version of the paper includes comments from the reviewers and is checked and edited for accuracy and readability.^[1]

Publisher

The journal is published by The Medical Letter, Inc., a nonprofit organization founded in 1958 by Arthur Kallet and Harold Aaron.^[2] It is independent of the pharmaceutical industry, supported by subscriptions, accepts no advertising, and has had a strict policy in place that in order to retain its objectivity, no reprints will be sold to the pharmaceutical industry.^{[citation needed]}

References

^ "Flowchart of the editorial process" (PDF). The Medical Letter, Inc. Retrieved 2010-06-29.
^ "The Medical Letter - 50th Anniversary". The Medical Letter on Drugs and Therapeutics. 51 (1304): 5. 2009.

External links

Official website

[1] "Flowchart of the editorial process" (PDF). The Medical Letter, Inc. Retrieved 2010-06-29.

[2] "The Medical Letter - 50th Anniversary". The Medical Letter on Drugs and Therapeutics. 51 (1304): 5. 2009.

[1]

[2]

@@ Line 1: / Line 1: @@
+{{more citations needed|date=April 2016}}
 {{Infobox journal
 | cover = <!-- Commented out because image was deleted: [[image:tml on drugs w-website.gif|200px|center]] -->
-| discipline = [[Publication]]
+| discipline = [[Pharmacology]]
-| language = English, French, Italian, Japanese, Spanish
+| language = English, French, Italian
 | abbreviation = Med. Lett. Drugs Ther.
 | publisher = [[The Medical Letter, Inc.]]
-| country = United States
+| country =
 | history = 1959-present
 | frequency = Biweekly
-| website = http://www.medicalletter.org/
+| website = http://secure.medicalletter.org/medicalletter
 | ISSN = 1523-2859
+| OCLC = 40606056
+| LCCN = 00211546
+| CODEN = MELEAP
 }}
-'''''The Medical Letter on Drugs and Therapeutics''''' (commonly referred to as ''The Medical Letter'') is a [[scientific journal]] providing evaluations of [[drug]]s. It has a print and electronic circulation of well over 450,000 subscribers in 125 countries worldwide.{{Citation needed|date=April 2011}}
+'''''The Medical Letter on Drugs and Therapeutics''''' (commonly referred to as ''The Medical Letter'') is a [[Peer review|peer-reviewed]] biweekly [[medical journal]] providing evaluations of [[pharmaceutical drug]]s. It is published in English, French, and Italian. The journal is abstracted and indexed in [[Index medicus]]/[[MEDLINE]]/[[PubMed]]. An offshoot, ''Treatment Guidelines from the Medical Letter'' ({{ISSN|1541-2792}}) was published from 2002 to 2014, when it was integrated into this journal.
-It is published biweekly (26 issues/year) in several languages: English (US and Canadian editions), French (Canadian and European editions), Italian, Japanese, and Spanish.
-''The Medical Letter'' is published by [[The Medical Letter, Inc.]], which also publishes the monthly ''[[Treatment Guidelines from The Medical Letter]]''.
 == Editorial process ==
-Articles for ''The Medical Letter'' are drafted by either an editor or external consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of [[clinical trial]]s. A preliminary draft is circulated to every member of the advisory board and 10-20 other investigators with relevant clinical or experimental experience with the article's topic. Drafts are also provided to the [[Food and Drug Administration]] (FDA) and [[Centers for Disease Control and Prevention]] (CDC) and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents. The final version of the paper includes comments from the reviewers and is checked and edited for accuracy and readability.<ref>{{cite web | url = http://medlet-best.securesites.com/downloads/Editorialchart.pdf | title = Flowchart of the editorial process | accessdate = 2010-06-29 | publisher = [[The Medical Letter, Inc.]] | format = pdf }}</ref>
+Articles for ''The Medical Letter'' are drafted by either an editor or external consultant using both published and available unpublished studies that are reviewed for methodological rigor with special attention to the results of [[clinical trial]]s. A preliminary draft is circulated to every member of the advisory board and 10-20 other investigators with relevant clinical or experimental experience with the article's topic. Drafts are also provided to the [[Food and Drug Administration]] and [[Centers for Disease Control and Prevention]] and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents. The final version of the paper includes comments from the reviewers and is checked and edited for accuracy and readability.<ref>{{cite web |url=http://medlet-best.securesites.com/downloads/Editorialchart.pdf |title=Flowchart of the editorial process |accessdate=2010-06-29 |publisher=[[The Medical Letter, Inc.]] |format=PDF}}</ref>
-== See also ==
+== Publisher ==
+The journal is published by The Medical Letter, Inc., a [[nonprofit organization]] founded in 1958 by [[Arthur Kallet]] and Harold Aaron.<ref>{{Cite journal |title=The Medical Letter - 50th Anniversary |url=https://secure.medicalletter.org/TML-article-1304d |journal=The Medical Letter on Drugs and Therapeutics |publication-date=2009 |volume=51 |issue=1304 |pages=5}}</ref> It is independent of the pharmaceutical industry,  supported  by subscriptions, accepts no advertising, and has had a strict policy in place that in order to retain its objectivity, no reprints will be sold to the pharmaceutical industry.{{citation needed|date=April 2016}}
-* [[List of medical journals]]
 == References ==
@@ Line 27: / Line 27: @@
 == External links ==
-* {{Official website|http://www.medicalletter.org}}
+* {{Official website|http://secure.medicalletter.org/medicalletter}}
 {{DEFAULTSORT:Medical Letter on Drugs and Therapeutics}}
+[[Category:Academic journals established in 1959]]
-[[Category:Publications established in 1959]]
 [[Category:Pharmacology journals]]
 [[Category:Multilingual journals]]
+[[Category:English-language journals]]
+[[Category:French-language journals]]
+[[Category:Italian-language journals]]
+[[Category:English-Italian multilingual journals]]
 [[Category:Biweekly journals]]